X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nsabp c-07 (57) 57
index medicus (48) 48
humans (46) 46
oncology (45) 45
oxaliplatin (41) 41
female (34) 34
male (34) 34
leucovorin (32) 32
neoplasm staging (32) 32
aged (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
fluorouracil (27) 27
middle aged (27) 27
chemotherapy (26) 26
colorectal-cancer (24) 24
colonic neoplasms - drug therapy (23) 23
colorectal cancer (23) 23
stage-ii (23) 23
survival (23) 23
chemotherapy, adjuvant (22) 22
cancer (21) 21
colonic neoplasms - pathology (21) 21
adjuvant chemotherapy (19) 19
therapy (19) 19
adult (18) 18
colon cancer (18) 18
organoplatinum compounds - administration & dosage (18) 18
prognosis (17) 17
weekly bolus fluorouracil (17) 17
adjuvant treatment (15) 15
aged, 80 and over (15) 15
colorectal neoplasms - drug therapy (15) 15
iii colon-cancer (15) 15
colorectal neoplasms - pathology (14) 14
fluorouracil - administration & dosage (14) 14
trial (14) 14
colonic neoplasms - mortality (12) 12
disease-free survival (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (11) 11
surgery (11) 11
treatment outcome (11) 11
capecitabine (10) 10
leucovorin - administration & dosage (10) 10
pooled analysis (9) 9
retrospective studies (9) 9
survival rate (9) 9
article (8) 8
colorectal neoplasms - surgery (8) 8
research (8) 8
antineoplastic agents (7) 7
colonic neoplasms - surgery (7) 7
elderly-patients (7) 7
gastroenterology & hepatology (7) 7
metastatic colorectal-cancer (7) 7
neoplasm recurrence, local - pathology (7) 7
organoplatinum compounds - therapeutic use (7) 7
young adult (7) 7
antimitotic agents (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
care and treatment (6) 6
colon-cancer (6) 6
drug therapy (6) 6
folinic acid (6) 6
follow-up studies (6) 6
hematology, oncology and palliative medicine (6) 6
leucovorin - therapeutic use (6) 6
medicine & public health (6) 6
microsatellite instability (6) 6
neurotoxicity (6) 6
organoplatinum compounds - adverse effects (6) 6
patients (6) 6
peripheral nervous system diseases - chemically induced (6) 6
surgical adjuvant chemotherapy (6) 6
adenocarcinoma - pathology (5) 5
adolescent (5) 5
carcinoma (5) 5
colonic neoplasms - genetics (5) 5
digestive system diseases (5) 5
fluorouracil - therapeutic use (5) 5
neoplasm recurrence, local - drug therapy (5) 5
oncology, experimental (5) 5
phase-iii (5) 5
proportional hazards models (5) 5
randomized controlled trials as topic (5) 5
randomized-trial (5) 5
recurrence (5) 5
risk factors (5) 5
time factors (5) 5
12-gene recurrence score (4) 4
1st-line treatment (4) 4
5-fluorouracil (4) 4
adjuvant therapy (4) 4
advanced colorectal-cancer (4) 4
analysis (4) 4
antineoplastic agents - therapeutic use (4) 4
cancer patients (4) 4
cancer therapies (4) 4
capecitabine - administration & dosage (4) 4
chemotherapy, adjuvant - methods (4) 4
clinical medicine (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 562 - 578
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 35, pp. 4176 - 4187
Journal Article
Journal Article
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, ISSN 1055-9965, 07/2019, Volume 28, Issue 7, pp. 1153 - 1161
Background: We explored and validated the association of postoperative carcinoembryonic antigen (CEA) with disease-free survival (DFS) and overall survival... 
ADJUVANT CHEMOTHERAPY | LEUCOVORIN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ONCOLOGY | CURATIVE RESECTION | FOLLOW-UP | PREDICTION MODEL | NSABP C-07 | OPEN-LABEL | OXALIPLATIN | RECURRENCE | FLUOROURACIL
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 862 - 873
Summary Background Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | ADJUVANT TREATMENT | NSABP C-07 | KRAS | COMBINATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Diarrhea - chemically induced | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Infusions, Intravenous - adverse effects | Adult | Female | Leucovorin - therapeutic use | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Cetuximab | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Exons - genetics | Proto-Oncogene Proteins - genetics | Adenocarcinoma - drug therapy | Mucositis - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Intention to Treat Analysis | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Prevention | Care and treatment | Chemotherapy | Colon cancer | Hospitals | Leucovorin | Product development | Cancer | Life Sciences
Journal Article
Cancer, ISSN 0008-543X, 01/2013, Volume 119, Issue 2, pp. 395 - 403
BACKGROUND: Randomized trials demonstrating the benefits of chemotherapy in patients with American Joint Committee on Cancer stage III colon cancer... 
elderly cancer care | chemotherapy | colon cancer | age disparities | LEUCOVORIN | WEEKLY BOLUS FLUOROURACIL | AGING POPULATION | OXALIPLATIN | THERAPY | ONCOLOGY | COLORECTAL-CANCER | POOLED ANALYSIS | NSABP C-07 | ELDERLY-PATIENTS | AGE
Journal Article
The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. e696 - e701
Background Anatomic location of primary tumors across the colon correlate with survival in the metastatic setting, whereas left‐sided tumors may exhibit... 
Tumor location | Prognostic biomarkers | Oncotype Recurrence Score assay | Stage II colorectal cancer | CDX2 | 12-GENE RECURRENCE SCORE | VALIDATION | ADJUVANT THERAPY | FLUOROURACIL | CHEMOTHERAPY | STAGE-II | II/III COLON-CANCER | ONCOLOGY | NSABP C-07 | EXPRESSION | Gastrointestinal Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1481 - 1492
Journal Article
Journal Article